drugset / Trial / NCT04621149

An Outpatient Study Investigating Non-prescription Treatments for COVID-19

NCT04621149

Phase 2 Terminated 10 enrolled Profact, Inc.
RandomizedFactorialQuadruple-blindTreatment

Summary

This is a platform study to investigate the effectiveness of a variety of non-prescription approaches for the treatment of non-hospitalized adults recently tested positive for COVID-19.

Timeline

Start
2020-11-15
Primary completion
2022-03-31
Completion
2022-03-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Famotidine Other / unclassified

Indications